SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Winfastorlose who wrote (1309755)7/27/2021 9:00:24 PM
From: Wharf Rat2 Recommendations

Recommended By
Brumar89
pocotrader

   of 1578928
 
Immune Response From mRNA COVID-19 Vaccines Is More Robust Than Natural Infection

May 3, 2021
Jonna Lorenz

Antibody levels induced by mRNA COVID-19 vaccines are much higher than those induced by natural infection and confer cross-reactivity that could be effective against new variants, a new study from the University of California, Irvine, found.

--
The study, published on the bioRxiv preprint server, used data from ongoing seroprevalence studies in Orange County, Calif., before and after a campaign to administer mRNA vaccines.

“MRNA vaccine induced antibody levels are spectacular and appear rapidly within a few days after vaccination,” corresponding author Philip Felgner, PhD, professor in residence and director of the Vaccine R&D Center at the University of California, Irvine told Contagion. “Only in our dreams we could have imagined a vaccine that that could be developed so quickly, works so well, can be manufactured at scale, distributed and administered to billions of people worldwide within months.”

contagionlive.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext